Overview
AOD-9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone (amino acids 176-191). It was developed to have the fat-reducing effects of GH without the growth-promoting activities. The peptide has been studied in clinical trials for obesity and has received regulatory approval in Australia for osteoarthritis treatment.
The peptide mimics the lipolytic (fat-burning) region of GH while lacking the IGF-1 stimulating effects. It is designed to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) without affecting blood sugar or tissue growth. The peptide interacts with beta-3 adrenergic receptors and modulates fat cell metabolism.
Research indicates AOD-9604 may also have regenerative properties in cartilage tissue, leading to regulatory approval in Australia for osteoarthritis treatment. Studies suggest the peptide promotes chondrocyte proliferation and proteoglycan synthesis in articular cartilage.
Mechanism of Action
AOD-9604 is believed to exert its effects by mimicking the action of human growth hormone (hGH) on fat metabolism. Specifically, it stimulates lipolysis, the breakdown of fat, and inhibits lipogenesis, the formation of fat, in a manner similar to hGH but without the undesirable growth-promoting effects.
The peptide interacts with beta-3 adrenergic receptors on adipocytes (fat cells), which triggers the release of fatty acids from these cells. This mechanism is separate from the hGH receptor and does not lead to IGF-1 stimulation, avoiding the potential for tissue growth stimulation and insulin resistance often associated with full hGH administration.
Furthermore, AOD-9604 appears to modulate cartilage metabolism through pathways distinct from its fat-metabolizing mechanisms. This may involve direct effects on chondrocyte growth factor receptors and regulation of matrix metalloproteinase activity, contributing to cartilage repair and regeneration.
Key Benefits
- Fat Metabolism Optimization
- Potential Cartilage Repair
- Selective GH Effects without Systemic Hormonal Impact
- Possible benefits to bone metabolism
Research & Indications
AOD-9604 has been studied primarily for its potential in obesity research, focusing on its ability to promote fat metabolism without the side effects associated with full growth hormone. Clinical trials have explored its safety and tolerability, as well as its effects on fat mass and body weight.
Research also indicates AOD-9604's regenerative properties in cartilage tissue, which led to regulatory approval in Australia for osteoarthritis treatment. Animal models of osteoarthritis have documented reduced cartilage degradation scores, improved joint function, and decreased inflammatory markers following AOD-9604 treatment regimens.
Emerging research suggests AOD-9604 may have beneficial effects on bone metabolism, potentially related to the same regenerative mechanisms underlying its cartilage repair properties.
Dosing Protocols
Disclaimer: This information is not medical advice. Consult with a qualified healthcare professional before using AOD-9604.
Clinical trials have used various dosages, typically in the 250-500 mcg range administered subcutaneously. Oral formulations have also been studied.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Fat Loss | 250-500 mcg | Once daily | Subcutaneous |
Supplies Needed
For an 8-16 week protocol:
- Peptide Vials: 4-10 vials (depending on dosage and vial size)
- Insulin Syringes (U-100): Sufficient quantity for daily injections
- Bacteriostatic Water: 2-3 × 10mL bottles
- Alcohol Swabs: One for vial + one for injection site daily
Side Effects & Safety
Clinical trials have generally reported AOD-9604 to be well-tolerated. However, as with any peptide, potential side effects may include injection site reactions, such as redness or itching. Long-term safety data is still limited, and more research is needed to fully assess potential risks.
Storage & Handling
Store lyophilized AOD-9604 at -20°C. Reconstitute with bacteriostatic water. Once reconstituted, store refrigerated and use within a reasonable period (e.g., within 14 days) for optimal stability.